163 related articles for article (PubMed ID: 37303939)
21. Long noncoding RNA SNHG16 contributes to the development of bladder cancer via regulating miR-98/STAT3/Wnt/β-catenin pathway axis.
Feng F; Chen A; Huang J; Xia Q; Chen Y; Jin X
J Cell Biochem; 2018 Nov; 119(11):9408-9418. PubMed ID: 30132983
[TBL] [Abstract][Full Text] [Related]
22. SNHG16 upregulation-induced positive feedback loop with YAP1/TEAD1 complex in Colorectal Cancer cell lines facilitates liver metastasis of colorectal cancer by modulating CTCs epithelial-mesenchymal transition.
Xiang Z; Huang G; Wu H; He Q; Yang C; Dou R; Liu Q; Song J; Fang Y; Wang S; Xiong B
Int J Biol Sci; 2022; 18(14):5291-5308. PubMed ID: 36147462
[TBL] [Abstract][Full Text] [Related]
23. Long Noncoding RNA SNHG16 Promotes Cell Proliferation by Sponging MicroRNA-205 and Upregulating ZEB1 Expression in Osteosarcoma.
Zhu C; Cheng D; Qiu X; Zhuang M; Liu Z
Cell Physiol Biochem; 2018; 51(1):429-440. PubMed ID: 30453308
[TBL] [Abstract][Full Text] [Related]
24. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway.
Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p/PIM1 axis.
Zhu Q; Li Y; Guo Y; Hu L; Xiao Z; Liu X; Wang J; Xu Q; Tong X
J Cell Mol Med; 2019 Nov; 23(11):7395-7405. PubMed ID: 31483572
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA SNHG16 promotes the tumorigenicity of cervical cancer cells by recruiting transcriptional factor SPI1 to upregulate PARP9.
Tao L; Wang X; Zhou Q
Cell Biol Int; 2020 Mar; 44(3):773-784. PubMed ID: 31774223
[TBL] [Abstract][Full Text] [Related]
27. Profile and validation of dysregulated long non‑coding RNAs and mRNAs in ovarian cancer.
Lu YM; Wang Y; Liu SQ; Zhou MY; Guo YR
Oncol Rep; 2018 Nov; 40(5):2964-2976. PubMed ID: 30132558
[TBL] [Abstract][Full Text] [Related]
28. SNHG16 promotes osteosarcoma progression and enhances cisplatin resistance by sponging miR-16 to upregulate ATG4B expression.
Liu Y; Gu S; Li H; Wang J; Wei C; Liu Q
Biochem Biophys Res Commun; 2019 Oct; 518(1):127-133. PubMed ID: 31427084
[TBL] [Abstract][Full Text] [Related]
29. LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis.
Wang X; Hu K; Chao Y; Wang L
Biomed Pharmacother; 2019 Jun; 114():108798. PubMed ID: 30909141
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA lnc-LOC645166 promotes adriamycin resistance via NF-κB/GATA3 axis in breast cancer.
Zheng R; Jia J; Guan L; Yuan H; Liu K; Liu C; Ye W; Liao Y; Lin S; Huang O
Aging (Albany NY); 2020 May; 12(10):8893-8912. PubMed ID: 32461377
[TBL] [Abstract][Full Text] [Related]
31. LncRNA SNHG16 promotes development of oesophageal squamous cell carcinoma by interacting with EIF4A3 and modulating RhoU mRNA stability.
Ren L; Fang X; Shrestha SM; Ji Q; Ye H; Liang Y; Liu Y; Feng Y; Dong J; Shi R
Cell Mol Biol Lett; 2022 Oct; 27(1):89. PubMed ID: 36221055
[TBL] [Abstract][Full Text] [Related]
32. Downregulated Long Noncoding RNA GAS5 Fails to Function as Decoy of CEBPB, Resulting in Increased GDF15 Expression and Rapid Ovarian Cancer Cell Proliferation.
Guo LL; Wang SF
Cancer Biother Radiopharm; 2019 Oct; 34(8):537-546. PubMed ID: 31314588
[No Abstract] [Full Text] [Related]
33. Down-regulation of SNHG16 alleviates the acute lung injury in sepsis rats through miR-128-3p/HMGB3 axis.
Sun J; Xin K; Leng C; Ge J
BMC Pulm Med; 2021 Jun; 21(1):191. PubMed ID: 34092219
[TBL] [Abstract][Full Text] [Related]
34. KHDRBS3 promotes paclitaxel resistance and induces glycolysis through modulated MIR17HG/CLDN6 signaling in epithelial ovarian cancer.
Wu X; Qiu L; Feng H; Zhang H; Yu H; Du Y; Wu H; Zhu S; Ruan Y; Jiang H
Life Sci; 2022 Mar; 293():120328. PubMed ID: 35051418
[TBL] [Abstract][Full Text] [Related]
35. SNHG16 regulates invasion and migration of bladder cancer through induction of epithelial-to-mesenchymal transition.
Chen W; Jiang T; Mao H; Gao R; Zhang H; He Y; Liu C; Chen Q
Hum Cell; 2020 Jul; 33(3):737-749. PubMed ID: 32207096
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone.
Sugimura M; Sagae S; Ishioka S; Nishioka Y; Tsukada K; Kudo R
Oncology; 2004; 66(1):53-61. PubMed ID: 15031599
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA CTSLP8 mediates ovarian cancer progression and chemotherapy resistance by modulating cellular glycolysis and regulating c-Myc expression through PKM2.
Li X; Zhang Y; Wang X; Lin F; Cheng X; Wang Z; Wang X
Cell Biol Toxicol; 2022 Dec; 38(6):1027-1045. PubMed ID: 34510316
[TBL] [Abstract][Full Text] [Related]
38. circANKRD17(has_circ_0007883) confers paclitaxel resistance of ovarian cancer via interacting with FUS to stabilize FOXR2.
Liang YX; Zhang LL; Yang L
Mol Cell Biochem; 2023 Apr; 478(4):835-850. PubMed ID: 36107285
[TBL] [Abstract][Full Text] [Related]
39. MiR-181c sensitizes ovarian cancer cells to paclitaxel by targeting GRP78 through the PI3K/Akt pathway.
Zhang LY; Yu JY; Leng YL; Zhu RR; Liu HX; Wang XY; Yang TT; Guo YN; Tang JL; Zhang XC
Cancer Gene Ther; 2022 Jun; 29(6):770-783. PubMed ID: 34145425
[TBL] [Abstract][Full Text] [Related]
40. Enhanced expression of the long non-coding RNA SNHG16 contributes to gastric cancer progression and metastasis.
Lian D; Amin B; Du D; Yan W
Cancer Biomark; 2017 Dec; 21(1):151-160. PubMed ID: 29081409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]